Hemant Surgical

{
  "main_header": {
    "sid": 1003854,
    "name": "Hemant Surgical",
    "stock_name": "Hemant Surgical",
    "full_name": "Hemant Surgical Industries Ltd",
    "name_url": "stocks-analysis/hemant-surgical",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "280.50",
    "chg": -16.5,
    "chgp": "-5.56%",
    "dir": -1,
    "prev_price": "297.00",
    "mcapval": "365.73 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543916,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE0GYI01028",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": 5200,
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hemant-surgical-1003854-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Hemant Surgical falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-hemant-surgical-fallingrising-3722310",
        "imagepath": "",
        "date": "2025-11-22 01:30:28",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>Hemant Surgical's share price decline on 21-Nov reflects a short-term correction after a period of strong gains. The stock underperformed its sector by 2.99% on the day, touching an intraday low of ₹275.05. This contrasts with the broader Sensex, which has shown modest positive returns over the past week and month. Specifically, while the Sensex gained 0.79% over the last week, Hemant Surgical's shares fell by 5.16% during the same period, indicating a divergence from general market trends.</p>\n<p>The stock's current price sits above its 100-day and 200-day moving averages, signalling a longer-term bullish trend. However, it remains below its 5-day, 20-day, and 50-day moving averages, suggesting recent downward momentum. This techn..."
      },
      {
        "title": "Is Hemant Surgical overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-hemant-surgical-overvalued-or-undervalued-3713644",
        "imagepath": "",
        "date": "2025-11-19 08:10:08",
        "description": "As of 18 November 2025, the valuation grade for Hemant Surgical has moved from very expensive to expensive. The company is currently considered overvalued. Key ratios include a PE ratio of 45.47, an EV to EBITDA of 38.49, and a Price to Book Value of 3.28. In comparison to peers, Max Healthcare has a significantly higher PE ratio of 77.03, while Apollo Hospitals is at 63.51, indicating that Hemant Surgical's valuation remains elevated relative to its competitors.\n\nDespite a strong year-to-date return of 124.64% compared to the Sensex's 8.36%, the high valuation ratios suggest that the stock is not justified at its current price of 283.50. The company's ROCE of 8.31% and ROE of 7.22% further indicate that while it has performed well, the market may be pricing in growth that is not fully supported by its financial metrics...."
      },
      {
        "title": "How has been the historical performance of Hemant Surgical?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-hemant-surgical-3695747",
        "imagepath": "",
        "date": "2025-11-13 00:37:59",
        "description": "Answer:\nThe historical performance of Hemant Surgical for the year ending March 2025 shows a total operating income of 106.64 crore, with a net profit after tax of 8.04 crore. The company reported an operating profit margin of 8.42% and a profit after tax margin of 7.54%. The earnings per share stood at 7.7, and the book value per share was 60.51. Total liabilities were recorded at 148.15 crore, with total assets also at 148.15 crore, indicating a balanced position. The cash flow from operating activities was 8.00 crore, while the net cash outflow for the period was 3.00 crore, resulting in a closing cash and cash equivalent of 9.00 crore.\n\nBreakdown:\nIn the fiscal year ending March 2025, Hemant Surgical achieved a total operating income of 106.64 crore, primarily driven by net sales. The company faced raw material costs of 94.26 crore, leading to a total expenditure of 97.66 crore, which resulted in an ope..."
      },
      {
        "title": "Why is Hemant Surgical falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-hemant-surgical-fallingrising-3695111",
        "imagepath": "",
        "date": "2025-11-13 00:07:58",
        "description": "As of 12-Nov, Hemant Surgical Industries Ltd is experiencing a price increase, currently at Rs 296.00, which reflects a rise of Rs 6.0 or 2.07%. The stock has shown a positive trend recently, gaining for three consecutive days with a total return of 5.87% during this period. Despite touching an intraday low of Rs 275.5, the stock reached a high of Rs 296 today. Over the past week, it has outperformed the sector by 2.48%. However, it is important to note that the delivery volume has decreased significantly by 52.1% compared to the five-day average, indicating a potential decline in investor participation. The stock's performance over the year has been strong, with a year-to-date return of 134.55%, significantly outpacing the Sensex's 8.10%.\n\nIn the broader market context, Hemant Surgical's short-term performance has been favorable compared to the benchmark, with a 1-week return of 2.07% versus the Sensex's 1..."
      },
      {
        "title": "Why is Hemant Surgical falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-hemant-surgical-fallingrising-3642221",
        "imagepath": "",
        "date": "2025-10-23 23:58:02",
        "description": "As of 23-Oct, Hemant Surgical Industries Ltd is experiencing a decline in its stock price, currently at 281.20, which reflects a decrease of 14.8 or 5.0%. The stock has shown erratic trading patterns, having not traded on one day out of the last 20 days. Additionally, the stock's delivery volume has significantly dropped by 81.48% compared to its 5-day average, indicating falling investor participation. Despite a strong year-to-date return of 122.82%, the stock has underperformed in the short term, with a 1-week decline of 7.62% and a 1-month decline of 21.85%. There is no information available regarding positive or negative factors that could be influencing the stock's recent movement.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has gained 1.30% over the past week and 2.99% over the past month, Hemant Surgical's performance has been notably weaker. The stock's recent declines cont..."
      }
    ],
    "total": 157,
    "sid": "1003854",
    "stock_news_url": "https://www.marketsmojo.com/news/hemant-surgical-industries-1003854"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "12-Jan-2026",
      "details": "Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018.",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "12-Nov-2025",
      "details": "Statement of Deviation or Variation for half year ended on September 30 2025",
      "source": "BSE"
    },
    {
      "caption": "Un-Audited Financial Results Of The Company For The Half Year Ended On September 30 2025.",
      "datetime": "12-Nov-2025",
      "details": "Unaudited financial results of the Company for the half year ended on September 30 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Hemant Surgical falling/rising?

2025-11-22 01:30:28

Short-Term Price Movement and Market Context

Hemant Surgical's share price decline on 21-Nov reflects a short-term correction after a period of strong gains. The stock underperformed its sector by 2.99% on the day, touching an intraday low of ₹275.05. This contrasts with the broader Sensex, which has shown modest positive returns over the past week and month. Specifically, while the Sensex gained 0.79% over the last week, Hemant Surgical's shares fell by 5.16% during the same period, indicating a divergence from general market trends.

The stock's current price sits above its 100-day and 200-day moving averages, signalling a longer-term bullish trend. However, it remains below its 5-day, 20-day, and 50-day moving averages, suggesting recent downward momentum. This techn...

Read full news article

Is Hemant Surgical overvalued or undervalued?

2025-11-19 08:10:08

As of 18 November 2025, the valuation grade for Hemant Surgical has moved from very expensive to expensive. The company is currently considered overvalued. Key ratios include a PE ratio of 45.47, an EV to EBITDA of 38.49, and a Price to Book Value of 3.28. In comparison to peers, Max Healthcare has a significantly higher PE ratio of 77.03, while Apollo Hospitals is at 63.51, indicating that Hemant Surgical's valuation remains elevated relative to its competitors. Despite a strong year-to-date return of 124.64% compared to the Sensex's 8.36%, the high valuation ratios suggest that the stock is not justified at its current price of 283.50. The company's ROCE of 8.31% and ROE of 7.22% further indicate that while it has performed well, the market may be pricing in growth that is not fully supported by its financial metrics....

Read full news article

How has been the historical performance of Hemant Surgical?

2025-11-13 00:37:59

Answer: The historical performance of Hemant Surgical for the year ending March 2025 shows a total operating income of 106.64 crore, with a net profit after tax of 8.04 crore. The company reported an operating profit margin of 8.42% and a profit after tax margin of 7.54%. The earnings per share stood at 7.7, and the book value per share was 60.51. Total liabilities were recorded at 148.15 crore, with total assets also at 148.15 crore, indicating a balanced position. The cash flow from operating activities was 8.00 crore, while the net cash outflow for the period was 3.00 crore, resulting in a closing cash and cash equivalent of 9.00 crore. Breakdown: In the fiscal year ending March 2025, Hemant Surgical achieved a total operating income of 106.64 crore, primarily driven by net sales. The company faced raw material costs of 94.26 crore, leading to a total expenditure of 97.66 crore, which resulted in an ope...

Read full news article

Why is Hemant Surgical falling/rising?

2025-11-13 00:07:58

As of 12-Nov, Hemant Surgical Industries Ltd is experiencing a price increase, currently at Rs 296.00, which reflects a rise of Rs 6.0 or 2.07%. The stock has shown a positive trend recently, gaining for three consecutive days with a total return of 5.87% during this period. Despite touching an intraday low of Rs 275.5, the stock reached a high of Rs 296 today. Over the past week, it has outperformed the sector by 2.48%. However, it is important to note that the delivery volume has decreased significantly by 52.1% compared to the five-day average, indicating a potential decline in investor participation. The stock's performance over the year has been strong, with a year-to-date return of 134.55%, significantly outpacing the Sensex's 8.10%. In the broader market context, Hemant Surgical's short-term performance has been favorable compared to the benchmark, with a 1-week return of 2.07% versus the Sensex's 1...

Read full news article

Why is Hemant Surgical falling/rising?

2025-10-23 23:58:02

As of 23-Oct, Hemant Surgical Industries Ltd is experiencing a decline in its stock price, currently at 281.20, which reflects a decrease of 14.8 or 5.0%. The stock has shown erratic trading patterns, having not traded on one day out of the last 20 days. Additionally, the stock's delivery volume has significantly dropped by 81.48% compared to its 5-day average, indicating falling investor participation. Despite a strong year-to-date return of 122.82%, the stock has underperformed in the short term, with a 1-week decline of 7.62% and a 1-month decline of 21.85%. There is no information available regarding positive or negative factors that could be influencing the stock's recent movement. Broader Market Context: In comparison to the benchmark Sensex, which has gained 1.30% over the past week and 2.99% over the past month, Hemant Surgical's performance has been notably weaker. The stock's recent declines cont...

Read full news article

View All News